In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy

Background We previously visualized in vivo responses to chemotherapy in a colorectal liver metastatic xenograft model using in vivo real-time and time-series intravital two-photon laser scanning microscopy (TPLSM). In this study, we established the method for evaluating the response of peritoneal x...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2015-01, Vol.18 (1), p.109-118
Hauptverfasser: Shimura, Tadanobu, Tanaka, Koji, Toiyama, Yuji, Okigami, Masato, Ide, Shozo, Kitajima, Takahito, Kondo, Satoru, Saigusa, Susumu, Ohi, Masaki, Araki, Toshimitsu, Inoue, Yasuhiro, Uchida, Keiichi, Mohri, Yasuhiko, Mizoguchi, Akira, Kusunoki, Masato
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 118
container_issue 1
container_start_page 109
container_title Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
container_volume 18
creator Shimura, Tadanobu
Tanaka, Koji
Toiyama, Yuji
Okigami, Masato
Ide, Shozo
Kitajima, Takahito
Kondo, Satoru
Saigusa, Susumu
Ohi, Masaki
Araki, Toshimitsu
Inoue, Yasuhiro
Uchida, Keiichi
Mohri, Yasuhiko
Mizoguchi, Akira
Kusunoki, Masato
description Background We previously visualized in vivo responses to chemotherapy in a colorectal liver metastatic xenograft model using in vivo real-time and time-series intravital two-photon laser scanning microscopy (TPLSM). In this study, we established the method for evaluating the response of peritoneal xenografts to chemotherapy of metastatic gastric cancer using intravital TPLSM. Methods Red fluorescent protein-expressing gastric cancer cells (NUGC4) were inoculated into the peritoneal cavity of green fluorescent protein nude mice. Results Laparotomy revealed that 2 weeks after inoculation, macroscopic peritoneal metastatic nodules were formed. The first intravital TPLSM session revealed that they were composed of red tumor cell clusters and green surrounding stroma. Paclitaxel was administered intraperitoneally after the first TPLSM three times a week for 7 days in the treatment group. At the second laparotomy, there were significantly fewer and smaller nodules in the treated mice than in the controls. The second intravital TPLSM session showed tumor cell fragmentation, swelling, and nuclear condensation in the metastatic nodules—a response to chemotherapy. There were multinuclear tumor cells in the paclitaxel-treated living mice. Conclusions Our method may become a powerful tool for evaluating the efficacy of novel anti-gastric cancer drugs in a preclinical murine model with minimum interindividual variation.
doi_str_mv 10.1007/s10120-013-0334-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1634278496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1634278496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c643t-2f6492a512a63ba4dcc97a923660aecb435295206ed88f300282b392872d86953</originalsourceid><addsrcrecordid>eNp1kc1u1TAUhC1ERUvLA7BBltiwCfVffOMlqgpUqsSGri1f5yQ3VWIH2ynNq_C0nOi2CCGx8s98M8fWEPKWs4-csd1l5owLVjEuKyalqtYX5IwrqSspWf3yeS8MPyWvc75njNeG61fkVChpjDLqjPy6CfRheIg0zmXwbqSzK4c4xn6lscODH4fiHmGk0HWoe7wOtByAzpCGEgOgZYLicnHop48QYp9cV-gUW3RhRo9aQsm74CHRJQ-hp-VnrOZDxAA6uozXGeWwKdPgU8w-zusFOencmOHN03pO7j5ff7_6Wt1--3Jz9em28lrJUolOKyNczYXTcu9U673ZOSOk1syB3ytZC1MLpqFtmk4yJhqxl0Y0O9E22tTynHw45s4p_lggFzsN2cM4ugBxyZZrqcSuUUYj-v4f9D4uKeDrNkrUnOMspPiR2n6SE3R2TsPk0mo5s1tx9licxeLsVpxd0fPuKXnZT9D-cTw3hYA4Ahml0EP6a_R_U38DT-il2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1632511529</pqid></control><display><type>article</type><title>In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Shimura, Tadanobu ; Tanaka, Koji ; Toiyama, Yuji ; Okigami, Masato ; Ide, Shozo ; Kitajima, Takahito ; Kondo, Satoru ; Saigusa, Susumu ; Ohi, Masaki ; Araki, Toshimitsu ; Inoue, Yasuhiro ; Uchida, Keiichi ; Mohri, Yasuhiko ; Mizoguchi, Akira ; Kusunoki, Masato</creator><creatorcontrib>Shimura, Tadanobu ; Tanaka, Koji ; Toiyama, Yuji ; Okigami, Masato ; Ide, Shozo ; Kitajima, Takahito ; Kondo, Satoru ; Saigusa, Susumu ; Ohi, Masaki ; Araki, Toshimitsu ; Inoue, Yasuhiro ; Uchida, Keiichi ; Mohri, Yasuhiko ; Mizoguchi, Akira ; Kusunoki, Masato</creatorcontrib><description>Background We previously visualized in vivo responses to chemotherapy in a colorectal liver metastatic xenograft model using in vivo real-time and time-series intravital two-photon laser scanning microscopy (TPLSM). In this study, we established the method for evaluating the response of peritoneal xenografts to chemotherapy of metastatic gastric cancer using intravital TPLSM. Methods Red fluorescent protein-expressing gastric cancer cells (NUGC4) were inoculated into the peritoneal cavity of green fluorescent protein nude mice. Results Laparotomy revealed that 2 weeks after inoculation, macroscopic peritoneal metastatic nodules were formed. The first intravital TPLSM session revealed that they were composed of red tumor cell clusters and green surrounding stroma. Paclitaxel was administered intraperitoneally after the first TPLSM three times a week for 7 days in the treatment group. At the second laparotomy, there were significantly fewer and smaller nodules in the treated mice than in the controls. The second intravital TPLSM session showed tumor cell fragmentation, swelling, and nuclear condensation in the metastatic nodules—a response to chemotherapy. There were multinuclear tumor cells in the paclitaxel-treated living mice. Conclusions Our method may become a powerful tool for evaluating the efficacy of novel anti-gastric cancer drugs in a preclinical murine model with minimum interindividual variation.</description><identifier>ISSN: 1436-3291</identifier><identifier>EISSN: 1436-3305</identifier><identifier>DOI: 10.1007/s10120-013-0334-y</identifier><identifier>PMID: 24399494</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Abdominal Surgery ; Animals ; Antineoplastic Agents, Phytogenic - administration &amp; dosage ; Antineoplastic Agents, Phytogenic - pharmacology ; Cancer Research ; Gastric cancer ; Gastroenterology ; Green Fluorescent Proteins - genetics ; Humans ; Luminescent Proteins - genetics ; Medicine ; Medicine &amp; Public Health ; Mice, Nude ; Mice, Transgenic ; Microscopy, Confocal - methods ; Oncology ; Original Article ; Paclitaxel - administration &amp; dosage ; Paclitaxel - pharmacology ; Peritoneal Neoplasms - drug therapy ; Peritoneal Neoplasms - secondary ; Red Fluorescent Protein ; Stomach Neoplasms - drug therapy ; Stomach Neoplasms - pathology ; Surgical Oncology ; Xenograft Model Antitumor Assays</subject><ispartof>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-01, Vol.18 (1), p.109-118</ispartof><rights>The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2014</rights><rights>The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c643t-2f6492a512a63ba4dcc97a923660aecb435295206ed88f300282b392872d86953</citedby><cites>FETCH-LOGICAL-c643t-2f6492a512a63ba4dcc97a923660aecb435295206ed88f300282b392872d86953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10120-013-0334-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10120-013-0334-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24399494$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimura, Tadanobu</creatorcontrib><creatorcontrib>Tanaka, Koji</creatorcontrib><creatorcontrib>Toiyama, Yuji</creatorcontrib><creatorcontrib>Okigami, Masato</creatorcontrib><creatorcontrib>Ide, Shozo</creatorcontrib><creatorcontrib>Kitajima, Takahito</creatorcontrib><creatorcontrib>Kondo, Satoru</creatorcontrib><creatorcontrib>Saigusa, Susumu</creatorcontrib><creatorcontrib>Ohi, Masaki</creatorcontrib><creatorcontrib>Araki, Toshimitsu</creatorcontrib><creatorcontrib>Inoue, Yasuhiro</creatorcontrib><creatorcontrib>Uchida, Keiichi</creatorcontrib><creatorcontrib>Mohri, Yasuhiko</creatorcontrib><creatorcontrib>Mizoguchi, Akira</creatorcontrib><creatorcontrib>Kusunoki, Masato</creatorcontrib><title>In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy</title><title>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</title><addtitle>Gastric Cancer</addtitle><addtitle>Gastric Cancer</addtitle><description>Background We previously visualized in vivo responses to chemotherapy in a colorectal liver metastatic xenograft model using in vivo real-time and time-series intravital two-photon laser scanning microscopy (TPLSM). In this study, we established the method for evaluating the response of peritoneal xenografts to chemotherapy of metastatic gastric cancer using intravital TPLSM. Methods Red fluorescent protein-expressing gastric cancer cells (NUGC4) were inoculated into the peritoneal cavity of green fluorescent protein nude mice. Results Laparotomy revealed that 2 weeks after inoculation, macroscopic peritoneal metastatic nodules were formed. The first intravital TPLSM session revealed that they were composed of red tumor cell clusters and green surrounding stroma. Paclitaxel was administered intraperitoneally after the first TPLSM three times a week for 7 days in the treatment group. At the second laparotomy, there were significantly fewer and smaller nodules in the treated mice than in the controls. The second intravital TPLSM session showed tumor cell fragmentation, swelling, and nuclear condensation in the metastatic nodules—a response to chemotherapy. There were multinuclear tumor cells in the paclitaxel-treated living mice. Conclusions Our method may become a powerful tool for evaluating the efficacy of novel anti-gastric cancer drugs in a preclinical murine model with minimum interindividual variation.</description><subject>Abdominal Surgery</subject><subject>Animals</subject><subject>Antineoplastic Agents, Phytogenic - administration &amp; dosage</subject><subject>Antineoplastic Agents, Phytogenic - pharmacology</subject><subject>Cancer Research</subject><subject>Gastric cancer</subject><subject>Gastroenterology</subject><subject>Green Fluorescent Proteins - genetics</subject><subject>Humans</subject><subject>Luminescent Proteins - genetics</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mice, Nude</subject><subject>Mice, Transgenic</subject><subject>Microscopy, Confocal - methods</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Paclitaxel - administration &amp; dosage</subject><subject>Paclitaxel - pharmacology</subject><subject>Peritoneal Neoplasms - drug therapy</subject><subject>Peritoneal Neoplasms - secondary</subject><subject>Red Fluorescent Protein</subject><subject>Stomach Neoplasms - drug therapy</subject><subject>Stomach Neoplasms - pathology</subject><subject>Surgical Oncology</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1436-3291</issn><issn>1436-3305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kc1u1TAUhC1ERUvLA7BBltiwCfVffOMlqgpUqsSGri1f5yQ3VWIH2ynNq_C0nOi2CCGx8s98M8fWEPKWs4-csd1l5owLVjEuKyalqtYX5IwrqSspWf3yeS8MPyWvc75njNeG61fkVChpjDLqjPy6CfRheIg0zmXwbqSzK4c4xn6lscODH4fiHmGk0HWoe7wOtByAzpCGEgOgZYLicnHop48QYp9cV-gUW3RhRo9aQsm74CHRJQ-hp-VnrOZDxAA6uozXGeWwKdPgU8w-zusFOencmOHN03pO7j5ff7_6Wt1--3Jz9em28lrJUolOKyNczYXTcu9U673ZOSOk1syB3ytZC1MLpqFtmk4yJhqxl0Y0O9E22tTynHw45s4p_lggFzsN2cM4ugBxyZZrqcSuUUYj-v4f9D4uKeDrNkrUnOMspPiR2n6SE3R2TsPk0mo5s1tx9licxeLsVpxd0fPuKXnZT9D-cTw3hYA4Ahml0EP6a_R_U38DT-il2w</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Shimura, Tadanobu</creator><creator>Tanaka, Koji</creator><creator>Toiyama, Yuji</creator><creator>Okigami, Masato</creator><creator>Ide, Shozo</creator><creator>Kitajima, Takahito</creator><creator>Kondo, Satoru</creator><creator>Saigusa, Susumu</creator><creator>Ohi, Masaki</creator><creator>Araki, Toshimitsu</creator><creator>Inoue, Yasuhiro</creator><creator>Uchida, Keiichi</creator><creator>Mohri, Yasuhiko</creator><creator>Mizoguchi, Akira</creator><creator>Kusunoki, Masato</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy</title><author>Shimura, Tadanobu ; Tanaka, Koji ; Toiyama, Yuji ; Okigami, Masato ; Ide, Shozo ; Kitajima, Takahito ; Kondo, Satoru ; Saigusa, Susumu ; Ohi, Masaki ; Araki, Toshimitsu ; Inoue, Yasuhiro ; Uchida, Keiichi ; Mohri, Yasuhiko ; Mizoguchi, Akira ; Kusunoki, Masato</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c643t-2f6492a512a63ba4dcc97a923660aecb435295206ed88f300282b392872d86953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Abdominal Surgery</topic><topic>Animals</topic><topic>Antineoplastic Agents, Phytogenic - administration &amp; dosage</topic><topic>Antineoplastic Agents, Phytogenic - pharmacology</topic><topic>Cancer Research</topic><topic>Gastric cancer</topic><topic>Gastroenterology</topic><topic>Green Fluorescent Proteins - genetics</topic><topic>Humans</topic><topic>Luminescent Proteins - genetics</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mice, Nude</topic><topic>Mice, Transgenic</topic><topic>Microscopy, Confocal - methods</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Paclitaxel - administration &amp; dosage</topic><topic>Paclitaxel - pharmacology</topic><topic>Peritoneal Neoplasms - drug therapy</topic><topic>Peritoneal Neoplasms - secondary</topic><topic>Red Fluorescent Protein</topic><topic>Stomach Neoplasms - drug therapy</topic><topic>Stomach Neoplasms - pathology</topic><topic>Surgical Oncology</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimura, Tadanobu</creatorcontrib><creatorcontrib>Tanaka, Koji</creatorcontrib><creatorcontrib>Toiyama, Yuji</creatorcontrib><creatorcontrib>Okigami, Masato</creatorcontrib><creatorcontrib>Ide, Shozo</creatorcontrib><creatorcontrib>Kitajima, Takahito</creatorcontrib><creatorcontrib>Kondo, Satoru</creatorcontrib><creatorcontrib>Saigusa, Susumu</creatorcontrib><creatorcontrib>Ohi, Masaki</creatorcontrib><creatorcontrib>Araki, Toshimitsu</creatorcontrib><creatorcontrib>Inoue, Yasuhiro</creatorcontrib><creatorcontrib>Uchida, Keiichi</creatorcontrib><creatorcontrib>Mohri, Yasuhiko</creatorcontrib><creatorcontrib>Mizoguchi, Akira</creatorcontrib><creatorcontrib>Kusunoki, Masato</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimura, Tadanobu</au><au>Tanaka, Koji</au><au>Toiyama, Yuji</au><au>Okigami, Masato</au><au>Ide, Shozo</au><au>Kitajima, Takahito</au><au>Kondo, Satoru</au><au>Saigusa, Susumu</au><au>Ohi, Masaki</au><au>Araki, Toshimitsu</au><au>Inoue, Yasuhiro</au><au>Uchida, Keiichi</au><au>Mohri, Yasuhiko</au><au>Mizoguchi, Akira</au><au>Kusunoki, Masato</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy</atitle><jtitle>Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</jtitle><stitle>Gastric Cancer</stitle><addtitle>Gastric Cancer</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>18</volume><issue>1</issue><spage>109</spage><epage>118</epage><pages>109-118</pages><issn>1436-3291</issn><eissn>1436-3305</eissn><abstract>Background We previously visualized in vivo responses to chemotherapy in a colorectal liver metastatic xenograft model using in vivo real-time and time-series intravital two-photon laser scanning microscopy (TPLSM). In this study, we established the method for evaluating the response of peritoneal xenografts to chemotherapy of metastatic gastric cancer using intravital TPLSM. Methods Red fluorescent protein-expressing gastric cancer cells (NUGC4) were inoculated into the peritoneal cavity of green fluorescent protein nude mice. Results Laparotomy revealed that 2 weeks after inoculation, macroscopic peritoneal metastatic nodules were formed. The first intravital TPLSM session revealed that they were composed of red tumor cell clusters and green surrounding stroma. Paclitaxel was administered intraperitoneally after the first TPLSM three times a week for 7 days in the treatment group. At the second laparotomy, there were significantly fewer and smaller nodules in the treated mice than in the controls. The second intravital TPLSM session showed tumor cell fragmentation, swelling, and nuclear condensation in the metastatic nodules—a response to chemotherapy. There were multinuclear tumor cells in the paclitaxel-treated living mice. Conclusions Our method may become a powerful tool for evaluating the efficacy of novel anti-gastric cancer drugs in a preclinical murine model with minimum interindividual variation.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>24399494</pmid><doi>10.1007/s10120-013-0334-y</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1436-3291
ispartof Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-01, Vol.18 (1), p.109-118
issn 1436-3291
1436-3305
language eng
recordid cdi_proquest_miscellaneous_1634278496
source MEDLINE; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings
subjects Abdominal Surgery
Animals
Antineoplastic Agents, Phytogenic - administration & dosage
Antineoplastic Agents, Phytogenic - pharmacology
Cancer Research
Gastric cancer
Gastroenterology
Green Fluorescent Proteins - genetics
Humans
Luminescent Proteins - genetics
Medicine
Medicine & Public Health
Mice, Nude
Mice, Transgenic
Microscopy, Confocal - methods
Oncology
Original Article
Paclitaxel - administration & dosage
Paclitaxel - pharmacology
Peritoneal Neoplasms - drug therapy
Peritoneal Neoplasms - secondary
Red Fluorescent Protein
Stomach Neoplasms - drug therapy
Stomach Neoplasms - pathology
Surgical Oncology
Xenograft Model Antitumor Assays
title In vivo optical pathology of paclitaxel efficacy on the peritoneal metastatic xenograft model of gastric cancer using two-photon laser scanning microscopy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A57%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20optical%20pathology%20of%20paclitaxel%20efficacy%20on%20the%20peritoneal%20metastatic%20xenograft%20model%20of%20gastric%20cancer%20using%20two-photon%20laser%20scanning%20microscopy&rft.jtitle=Gastric%20cancer%20:%20official%20journal%20of%20the%20International%20Gastric%20Cancer%20Association%20and%20the%20Japanese%20Gastric%20Cancer%20Association&rft.au=Shimura,%20Tadanobu&rft.date=2015-01-01&rft.volume=18&rft.issue=1&rft.spage=109&rft.epage=118&rft.pages=109-118&rft.issn=1436-3291&rft.eissn=1436-3305&rft_id=info:doi/10.1007/s10120-013-0334-y&rft_dat=%3Cproquest_cross%3E1634278496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1632511529&rft_id=info:pmid/24399494&rfr_iscdi=true